Management of co-infection with HIV and TB

Open Access
Publisher Website
Google Scholar
Abstract
References 1.↵ WHO .Tuberculosis: strategy and operations (www.who.int/gtb/policyrd/TBHIV.htm). (Accessed 10 Nov 2001.) 2.↵ UNAIDS .AIDS epidemic update: December 2000.Geneva:UNAIDS,2000.www.unaids.org/epidemic_update/report_dec00/index_dec.html (accessed 10 Nov 2001). 3.↵ Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al .Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.Lancet1998; 352:1725–1730. 4.↵Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations, United States, 2001.Am J Respir Crit Care Med2001; 164:1319–1320. 5.↵ Quigley MA, Mwinga A, Hosp M, Lisse I, Fuchs D, Porter JDH, et al .Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.AIDS2001; 15:215–222. 6.↵ Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L, et al .Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.AIDS1995; 9:267–273. 7.↵ Murray J, Sonnenberg P, Shearer SC, Godfrey FP .Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.Am J Respir Crit Care Med1999; 159:733–740. 8.↵ El Sadr WM, Perlman DC, Denning E, Matts JP, Cohn DL .A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes.Clin Infect Dis2001; 32:623–632. 9.↵ Burman WJ, Jones BE .Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.Am J Respir Crit Care Med2001; 164:7–12. 10.↵ Wiktor SZ, Sassan MM, Grant AD, Abouya L, Karon JM, Maurice C, et al .Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.Lancet1999; 353:1469–1475. 11.↵ Anglaret X .Trimethoprim-sulfamethoxazole prophylaxis in sub-Saharan Africa.Lancet2001; 358:1027–1028. 12.↵ Fitzgerald D, Desvarieux M, Severe P, Joseph P, Johnson W, Pape J .Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomized trial.Lancet2000; 356:1470–1474.